Corrigendum to "Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease" [The Journal of Pediatrics volume 239 (2021) P155 - 160]
- PMID: 40571467
- DOI: 10.1016/j.jpeds.2025.114677
Corrigendum to "Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease" [The Journal of Pediatrics volume 239 (2021) P155 - 160]
Erratum for
-
Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.J Pediatr. 2021 Dec;239:155-160. doi: 10.1016/j.jpeds.2021.08.041. Epub 2021 Aug 27. J Pediatr. 2021. PMID: 34454951
Similar articles
-
Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.J Pediatr. 2021 Dec;239:155-160. doi: 10.1016/j.jpeds.2021.08.041. Epub 2021 Aug 27. J Pediatr. 2021. PMID: 34454951
-
Outbreak of Severe Obesity and Metabolic Complications in Children and Adolescents Using the Korea National School Health Examination (KNSHE) From 2017 to 2021.J Korean Med Sci. 2025 Jul 21;40(28):e160. doi: 10.3346/jkms.2025.40.e160. J Korean Med Sci. 2025. PMID: 40696525 Free PMC article.
-
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.Aliment Pharmacol Ther. 2018 Jan;47(1):16-25. doi: 10.1111/apt.14401. Epub 2017 Oct 30. Aliment Pharmacol Ther. 2018. PMID: 29083036
-
Nonalcoholic fatty liver disease: a systematic review.JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287
-
Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children.World J Pediatr. 2024 Apr;20(4):413-421. doi: 10.1007/s12519-023-00704-y. Epub 2023 Apr 1. World J Pediatr. 2024. PMID: 37004681
Publication types
LinkOut - more resources
Full Text Sources